Astrana Health, Inc. Schedules 2025 Fourth Quarter and Year-End Financial Results Release and Conference Call
Rhea-AI Summary
Astrana Health (NASDAQ: ASTH) will release its fourth quarter and full-year 2025 financial results before market open on Monday, March 2, 2026. The company will host a conference call the same day at 5:30 a.m. PT / 8:30 a.m. ET to discuss results. A slide presentation (PDF) will be posted to the IR Calendar page after the release. The call is accessible by dial-in or live webcast, and a recording will be available after the call.
Positive
- None.
Negative
- None.
News Market Reaction – ASTH
On the day this news was published, ASTH gained 0.22%, reflecting a mild positive market reaction. Argus tracked a trough of -21.3% from its starting point during tracking. Our momentum scanner triggered 33 alerts that day, indicating elevated trading interest and price volatility. This price movement added approximately $3M to the company's valuation, bringing the market cap to $1.37B at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
ASTH was down 1.59% with mixed peer moves: MD (-2.71%), PIII (-9.29%), SEM (-0.33%), PACS (+0.06%), TVTY (0%). No momentum scanner confirmation of a sector-wide move.
Previous Conferences,earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Oct 15 | Earnings call scheduling | Neutral | +2.8% | Announced Q3 2025 results release date and conference call logistics. |
| Jul 22 | Earnings call scheduling | Neutral | +2.1% | Set Q2 2025 earnings release timing and investor call details. |
| Apr 15 | Earnings call scheduling | Neutral | -3.1% | Outlined Q1 2025 earnings release date and webcast information. |
| Feb 17 | Earnings call scheduling | Neutral | -0.1% | Announced schedule for Q4 and full-year 2024 results and call. |
| Oct 23 | Earnings call scheduling | Neutral | -5.6% | Set Q3 2024 earnings release date and call participation details. |
Scheduling earnings and conference calls has produced mixed single-day reactions, with both modest gains and pullbacks around such announcements.
This announcement continues Astrana’s pattern of pre-announcing quarterly earnings dates and investor calls. Prior scheduling releases for Q1, Q2, and Q3 2025, as well as late 2024, saw price moves ranging from about -5.6% to +2.8%. Alongside these, the company has reported strong revenue growth and closed the Prospect acquisition, with notable moves such as the Q2 2025 results reaction of +30.85%. Today’s notice fits that established communications cadence ahead of detailed results.
Historical Comparison
In the past, five Astrana scheduling releases tagged “conferences,earnings” saw an average move of 2.76%. Today’s similar announcement fits that recurring pattern of pre-earnings communication.
Regular quarterly cadence of scheduling earnings releases and conference calls from Q3 2024 through full-year 2024 and each quarter of 2025.
Market Pulse Summary
This announcement sets the timetable for Astrana’s Q4 and full-year 2025 results, to be released on March 2, 2026 before market open, followed by an early-morning conference call. It continues a consistent pattern of pre-announcing quarterly earnings dates and investor access details. Given prior volatility around detailed results and guidance, investors may focus on the upcoming numbers and management commentary, including any updates to growth trends and integration of past acquisitions.
AI-generated analysis. Not financial advice.
Participant Dial-in Numbers: 877-858-9810 / +1 201-689-8517
To access the call, please dial in approximately five minutes before start time. An accompanying slide presentation will be available in PDF format on the "IR Calendar" page of the Company's website (https://ir.astranahealth.com/news-events/ir-calendar) after issuance of the earnings release.
Webcast:
The call will also be available via online webcast at: https://event.choruscall.com/mediaframe/webcast.html?webcastid=CAALhYDU
Those who are unable to attend the live conference call may access the recording at the above webcast link, which will be made available shortly after the conclusion of the call.
About Astrana Health, Inc.
Astrana Health is a physician-centric, AI-powered healthcare company committed to delivering high-quality, patient-centered care. Built from the physician's perspective, Astrana combines its scalable care delivery infrastructure, proprietary technology platform, and aligned provider networks to enable proactive, preventive care at scale - improving patient outcomes, enhancing patient experiences, supporting provider well-being, and driving greater value across the healthcare system.
Today, Astrana supports more than 20,000 providers and over 1.6 million patients in value-based care arrangements through its affiliated provider networks, management services organization, and integrated care delivery clinics spanning primary, specialty, and ancillary care. Together, Astrana is building the healthcare system we all deserve - one that delivers better care, better experiences, and better outcomes for all. For more information, visit www.astranahealth.com.
FOR MORE INFORMATION, PLEASE CONTACT:
Jim McMillan, Investor Relations
jim.mcmillan@astranahealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/astrana-health-inc-schedules-2025-fourth-quarter-and-year-end-financial-results-release-and-conference-call-302669530.html
SOURCE Astrana Health, Inc.
FAQ
When will Astrana Health (ASTH) report Q4 and year-end 2025 results?
What time is the Astrana Health (ASTH) earnings call for March 2, 2026?
How can investors join the Astrana Health (ASTH) earnings call?
Will Astrana Health (ASTH) provide slides with the March 2, 2026 results?
Can I access a recording of Astrana Health's (ASTH) March 2, 2026 call later?
What should listeners do before joining Astrana Health's (ASTH) March 2, 2026 call?
